カテゴリー： 世界, 医療/バイオ, LP Information

世界の組換えストレプトキナーゼ市場予測 2023年-2029年

【英語タイトル】Global Recombinant Streptokinase Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC01063）・商品コード：LP23DC01063
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：98
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の組換えストレプトキナーゼ市場」は、過去の販売実績から2022年の世界の組換えストレプトキナーゼの総販売量を検討し、2023年から2029年の予測される組換えストレプトキナーゼの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の組換えストレプトキナーゼの市場規模を掲載し、XXX百万米ドル規模の世界の組換えストレプトキナーゼ市場の詳細な分析を提供します。本インサイトレポートは、世界の組換えストレプトキナーゼ業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の組換えストレプトキナーゼ市場における各社の独自のポジションをより深く理解するために、組換えストレプトキナーゼ製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の組換えストレプトキナーゼ市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。組換えストレプトキナーゼの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。組換えストレプトキナーゼの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。組換えストレプトキナーゼのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

組換えストレプトキナーゼの世界主要メーカーとしては、Abbott、 Biocon、 Win Medicare、 Bharat Biotech、 Taj Pharma、 Stanex Drugs and Chemicals Pvt. Ltd.、 Qingdao Guoda Biopharmaceutical Co., Ltd.、 Shanghai Chemo Wanbang Biophamaなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の組換えストレプトキナーゼ市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では組換えストレプトキナーゼ市場をセグメンテーションし、種類別 (注射剤、凍結乾燥品)、用途別 (病院薬局、小売薬局、オンライン薬局)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：注射剤、凍結乾燥品

・用途別区分：病院薬局、小売薬局、オンライン薬局

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の組換えストレプトキナーゼ市場の10年間の市場状況・展望は？
・世界および地域別に見た組換えストレプトキナーゼ市場成長の要因は何か？
・組換えストレプトキナーゼの市場機会はエンドマーケットの規模によってどのように変化するのか？
・組換えストレプトキナーゼのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：組換えストレプトキナーゼの年間販売量2018-2029、地域別現状・将来分析
・組換えストレプトキナーゼの種類別セグメント：注射剤、凍結乾燥品
・組換えストレプトキナーゼの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・組換えストレプトキナーゼの用途別セグメント：病院薬局、小売薬局、オンライン薬局
・組換えストレプトキナーゼの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の組換えストレプトキナーゼ市場
・企業別のグローバル組換えストレプトキナーゼ市場データ：2018-2023年の年間販売量、市場シェア
・企業別の組換えストレプトキナーゼの年間売上：2018-2023年の売上、市場シェア
・企業別の組換えストレプトキナーゼ販売価格
・主要企業の組換えストレプトキナーゼ生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

組換えストレプトキナーゼの地域別レビュー
・地域別の組換えストレプトキナーゼ市場規模2018-2023：年間販売量、売上
・主要国別の組換えストレプトキナーゼ市場規模2018-2023：年間販売量、売上
・南北アメリカの組換えストレプトキナーゼ販売の成長
・アジア太平洋の組換えストレプトキナーゼ販売の成長
・ヨーロッパの組換えストレプトキナーゼ販売の成長
・中東・アフリカの組換えストレプトキナーゼ販売の成長

南北アメリカ市場
・南北アメリカの国別の組換えストレプトキナーゼ販売量、売上（2018-2023）
・南北アメリカの組換えストレプトキナーゼの種類別販売量
・南北アメリカの組換えストレプトキナーゼの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の組換えストレプトキナーゼ販売量、売上（2018-2023）
・アジア太平洋の組換えストレプトキナーゼの種類別販売量
・アジア太平洋の組換えストレプトキナーゼの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の組換えストレプトキナーゼ販売量、売上（2018-2023）
・ヨーロッパの組換えストレプトキナーゼの種類別販売量
・ヨーロッパの組換えストレプトキナーゼの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の組換えストレプトキナーゼ販売量、売上（2018-2023）
・中東・アフリカの組換えストレプトキナーゼの種類別販売量
・中東・アフリカの組換えストレプトキナーゼの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・組換えストレプトキナーゼの製造コスト構造分析
・組換えストレプトキナーゼの製造プロセス分析
・組換えストレプトキナーゼの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・組換えストレプトキナーゼの主要なグローバル販売業者
・組換えストレプトキナーゼの主要なグローバル顧客

地域別の組換えストレプトキナーゼ市場予測レビュー
・地域別の組換えストレプトキナーゼ市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・組換えストレプトキナーゼの種類別市場規模予測
・組換えストレプトキナーゼの用途別市場規模予測

主要企業分析
Abbott、 Biocon、 Win Medicare、 Bharat Biotech、 Taj Pharma、 Stanex Drugs and Chemicals Pvt. Ltd.、 Qingdao Guoda Biopharmaceutical Co., Ltd.、 Shanghai Chemo Wanbang Biophama
・企業情報
・組換えストレプトキナーゼ製品
・組換えストレプトキナーゼ販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Recombinant Streptokinase market size is projected to grow from US$ 63 million in 2022 to US$ 81 million in 2029; it is expected to grow at a CAGR of 3.7% from 2023 to 2029.
United States market for Recombinant Streptokinase is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Recombinant Streptokinase is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Recombinant Streptokinase is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Recombinant Streptokinase players cover Abbott, Biocon, Win Medicare, Bharat Biotech, Taj Pharma, Stanex Drugs and Chemicals Pvt. Ltd., Qingdao Guoda Biopharmaceutical Co., Ltd. and Shanghai Chemo Wanbang Biophama, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Recombinant Streptokinase Industry Forecast” looks at past sales and reviews total world Recombinant Streptokinase sales in 2022, providing a comprehensive analysis by region and market sector of projected Recombinant Streptokinase sales for 2023 through 2029. With Recombinant Streptokinase sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Streptokinase industry.
This Insight Report provides a comprehensive analysis of the global Recombinant Streptokinase landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant Streptokinase portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Recombinant Streptokinase market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Streptokinase and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Streptokinase.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Streptokinase market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Injection
Lyophilized
Segmentation by application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Abbott
Biocon
Win Medicare
Bharat Biotech
Taj Pharma
Stanex Drugs and Chemicals Pvt. Ltd.
Qingdao Guoda Biopharmaceutical Co., Ltd.
Shanghai Chemo Wanbang Biophama
Key Questions Addressed in this Report
What is the 10-year outlook for the global Recombinant Streptokinase market?
What factors are driving Recombinant Streptokinase market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Recombinant Streptokinase market opportunities vary by end market size?
How does Recombinant Streptokinase break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Recombinant Streptokinase Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Recombinant Streptokinase by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Recombinant Streptokinase by Country/Region, 2018, 2022 & 2029
2.2 Recombinant Streptokinase Segment by Type
2.2.1 Injection
2.2.2 Lyophilized
2.3 Recombinant Streptokinase Sales by Type
2.3.1 Global Recombinant Streptokinase Sales Market Share by Type (2018-2023)
2.3.2 Global Recombinant Streptokinase Revenue and Market Share by Type (2018-2023)
2.3.3 Global Recombinant Streptokinase Sale Price by Type (2018-2023)
2.4 Recombinant Streptokinase Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Recombinant Streptokinase Sales by Application
2.5.1 Global Recombinant Streptokinase Sale Market Share by Application (2018-2023)
2.5.2 Global Recombinant Streptokinase Revenue and Market Share by Application (2018-2023)
2.5.3 Global Recombinant Streptokinase Sale Price by Application (2018-2023)
3 Global Recombinant Streptokinase by Company
3.1 Global Recombinant Streptokinase Breakdown Data by Company
3.1.1 Global Recombinant Streptokinase Annual Sales by Company (2018-2023)
3.1.2 Global Recombinant Streptokinase Sales Market Share by Company (2018-2023)
3.2 Global Recombinant Streptokinase Annual Revenue by Company (2018-2023)
3.2.1 Global Recombinant Streptokinase Revenue by Company (2018-2023)
3.2.2 Global Recombinant Streptokinase Revenue Market Share by Company (2018-2023)
3.3 Global Recombinant Streptokinase Sale Price by Company
3.4 Key Manufacturers Recombinant Streptokinase Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Recombinant Streptokinase Product Location Distribution
3.4.2 Players Recombinant Streptokinase Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Recombinant Streptokinase by Geographic Region
4.1 World Historic Recombinant Streptokinase Market Size by Geographic Region (2018-2023)
4.1.1 Global Recombinant Streptokinase Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Recombinant Streptokinase Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Recombinant Streptokinase Market Size by Country/Region (2018-2023)
4.2.1 Global Recombinant Streptokinase Annual Sales by Country/Region (2018-2023)
4.2.2 Global Recombinant Streptokinase Annual Revenue by Country/Region (2018-2023)
4.3 Americas Recombinant Streptokinase Sales Growth
4.4 APAC Recombinant Streptokinase Sales Growth
4.5 Europe Recombinant Streptokinase Sales Growth
4.6 Middle East & Africa Recombinant Streptokinase Sales Growth
5 Americas
5.1 Americas Recombinant Streptokinase Sales by Country
5.1.1 Americas Recombinant Streptokinase Sales by Country (2018-2023)
5.1.2 Americas Recombinant Streptokinase Revenue by Country (2018-2023)
5.2 Americas Recombinant Streptokinase Sales by Type
5.3 Americas Recombinant Streptokinase Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant Streptokinase Sales by Region
6.1.1 APAC Recombinant Streptokinase Sales by Region (2018-2023)
6.1.2 APAC Recombinant Streptokinase Revenue by Region (2018-2023)
6.2 APAC Recombinant Streptokinase Sales by Type
6.3 APAC Recombinant Streptokinase Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Recombinant Streptokinase by Country
7.1.1 Europe Recombinant Streptokinase Sales by Country (2018-2023)
7.1.2 Europe Recombinant Streptokinase Revenue by Country (2018-2023)
7.2 Europe Recombinant Streptokinase Sales by Type
7.3 Europe Recombinant Streptokinase Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Recombinant Streptokinase by Country
8.1.1 Middle East & Africa Recombinant Streptokinase Sales by Country (2018-2023)
8.1.2 Middle East & Africa Recombinant Streptokinase Revenue by Country (2018-2023)
8.2 Middle East & Africa Recombinant Streptokinase Sales by Type
8.3 Middle East & Africa Recombinant Streptokinase Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Recombinant Streptokinase
10.3 Manufacturing Process Analysis of Recombinant Streptokinase
10.4 Industry Chain Structure of Recombinant Streptokinase
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Recombinant Streptokinase Distributors
11.3 Recombinant Streptokinase Customer
12 World Forecast Review for Recombinant Streptokinase by Geographic Region
12.1 Global Recombinant Streptokinase Market Size Forecast by Region
12.1.1 Global Recombinant Streptokinase Forecast by Region (2024-2029)
12.1.2 Global Recombinant Streptokinase Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Recombinant Streptokinase Forecast by Type
12.7 Global Recombinant Streptokinase Forecast by Application
13 Key Players Analysis
13.1 Abbott
13.1.1 Abbott Company Information
13.1.2 Abbott Recombinant Streptokinase Product Portfolios and Specifications
13.1.3 Abbott Recombinant Streptokinase Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Abbott Main Business Overview
13.1.5 Abbott Latest Developments
13.2 Biocon
13.2.1 Biocon Company Information
13.2.2 Biocon Recombinant Streptokinase Product Portfolios and Specifications
13.2.3 Biocon Recombinant Streptokinase Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Biocon Main Business Overview
13.2.5 Biocon Latest Developments
13.3 Win Medicare
13.3.1 Win Medicare Company Information
13.3.2 Win Medicare Recombinant Streptokinase Product Portfolios and Specifications
13.3.3 Win Medicare Recombinant Streptokinase Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Win Medicare Main Business Overview
13.3.5 Win Medicare Latest Developments
13.4 Bharat Biotech
13.4.1 Bharat Biotech Company Information
13.4.2 Bharat Biotech Recombinant Streptokinase Product Portfolios and Specifications
13.4.3 Bharat Biotech Recombinant Streptokinase Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Bharat Biotech Main Business Overview
13.4.5 Bharat Biotech Latest Developments
13.5 Taj Pharma
13.5.1 Taj Pharma Company Information
13.5.2 Taj Pharma Recombinant Streptokinase Product Portfolios and Specifications
13.5.3 Taj Pharma Recombinant Streptokinase Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Taj Pharma Main Business Overview
13.5.5 Taj Pharma Latest Developments
13.6 Stanex Drugs and Chemicals Pvt. Ltd.
13.6.1 Stanex Drugs and Chemicals Pvt. Ltd. Company Information
13.6.2 Stanex Drugs and Chemicals Pvt. Ltd. Recombinant Streptokinase Product Portfolios and Specifications
13.6.3 Stanex Drugs and Chemicals Pvt. Ltd. Recombinant Streptokinase Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Stanex Drugs and Chemicals Pvt. Ltd. Main Business Overview
13.6.5 Stanex Drugs and Chemicals Pvt. Ltd. Latest Developments
13.7 Qingdao Guoda Biopharmaceutical Co., Ltd.
13.7.1 Qingdao Guoda Biopharmaceutical Co., Ltd. Company Information
13.7.2 Qingdao Guoda Biopharmaceutical Co., Ltd. Recombinant Streptokinase Product Portfolios and Specifications
13.7.3 Qingdao Guoda Biopharmaceutical Co., Ltd. Recombinant Streptokinase Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Qingdao Guoda Biopharmaceutical Co., Ltd. Main Business Overview
13.7.5 Qingdao Guoda Biopharmaceutical Co., Ltd. Latest Developments
13.8 Shanghai Chemo Wanbang Biophama
13.8.1 Shanghai Chemo Wanbang Biophama Company Information
13.8.2 Shanghai Chemo Wanbang Biophama Recombinant Streptokinase Product Portfolios and Specifications
13.8.3 Shanghai Chemo Wanbang Biophama Recombinant Streptokinase Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Shanghai Chemo Wanbang Biophama Main Business Overview
13.8.5 Shanghai Chemo Wanbang Biophama Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Recombinant Streptokinase Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Recombinant Streptokinase Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Lyophilized
Table 5. Global Recombinant Streptokinase Sales by Type (2018-2023) & (K Units)
Table 6. Global Recombinant Streptokinase Sales Market Share by Type (2018-2023)
Table 7. Global Recombinant Streptokinase Revenue by Type (2018-2023) & ($ million)
Table 8. Global Recombinant Streptokinase Revenue Market Share by Type (2018-2023)
Table 9. Global Recombinant Streptokinase Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Recombinant Streptokinase Sales by Application (2018-2023) & (K Units)
Table 11. Global Recombinant Streptokinase Sales Market Share by Application (2018-2023)
Table 12. Global Recombinant Streptokinase Revenue by Application (2018-2023)
Table 13. Global Recombinant Streptokinase Revenue Market Share by Application (2018-2023)
Table 14. Global Recombinant Streptokinase Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Recombinant Streptokinase Sales by Company (2018-2023) & (K Units)
Table 16. Global Recombinant Streptokinase Sales Market Share by Company (2018-2023)
Table 17. Global Recombinant Streptokinase Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Recombinant Streptokinase Revenue Market Share by Company (2018-2023)
Table 19. Global Recombinant Streptokinase Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Recombinant Streptokinase Producing Area Distribution and Sales Area
Table 21. Players Recombinant Streptokinase Products Offered
Table 22. Recombinant Streptokinase Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Recombinant Streptokinase Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Recombinant Streptokinase Sales Market Share Geographic Region (2018-2023)
Table 27. Global Recombinant Streptokinase Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Recombinant Streptokinase Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Recombinant Streptokinase Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Recombinant Streptokinase Sales Market Share by Country/Region (2018-2023)
Table 31. Global Recombinant Streptokinase Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Recombinant Streptokinase Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Recombinant Streptokinase Sales by Country (2018-2023) & (K Units)
Table 34. Americas Recombinant Streptokinase Sales Market Share by Country (2018-2023)
Table 35. Americas Recombinant Streptokinase Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Recombinant Streptokinase Revenue Market Share by Country (2018-2023)
Table 37. Americas Recombinant Streptokinase Sales by Type (2018-2023) & (K Units)
Table 38. Americas Recombinant Streptokinase Sales by Application (2018-2023) & (K Units)
Table 39. APAC Recombinant Streptokinase Sales by Region (2018-2023) & (K Units)
Table 40. APAC Recombinant Streptokinase Sales Market Share by Region (2018-2023)
Table 41. APAC Recombinant Streptokinase Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Recombinant Streptokinase Revenue Market Share by Region (2018-2023)
Table 43. APAC Recombinant Streptokinase Sales by Type (2018-2023) & (K Units)
Table 44. APAC Recombinant Streptokinase Sales by Application (2018-2023) & (K Units)
Table 45. Europe Recombinant Streptokinase Sales by Country (2018-2023) & (K Units)
Table 46. Europe Recombinant Streptokinase Sales Market Share by Country (2018-2023)
Table 47. Europe Recombinant Streptokinase Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Recombinant Streptokinase Revenue Market Share by Country (2018-2023)
Table 49. Europe Recombinant Streptokinase Sales by Type (2018-2023) & (K Units)
Table 50. Europe Recombinant Streptokinase Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Recombinant Streptokinase Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Recombinant Streptokinase Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Recombinant Streptokinase Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Recombinant Streptokinase Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Recombinant Streptokinase Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Recombinant Streptokinase Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Recombinant Streptokinase
Table 58. Key Market Challenges & Risks of Recombinant Streptokinase
Table 59. Key Industry Trends of Recombinant Streptokinase
Table 60. Recombinant Streptokinase Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Recombinant Streptokinase Distributors List
Table 63. Recombinant Streptokinase Customer List
Table 64. Global Recombinant Streptokinase Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Recombinant Streptokinase Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Recombinant Streptokinase Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Recombinant Streptokinase Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Recombinant Streptokinase Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Recombinant Streptokinase Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Recombinant Streptokinase Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Recombinant Streptokinase Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Recombinant Streptokinase Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Recombinant Streptokinase Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Recombinant Streptokinase Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Recombinant Streptokinase Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Recombinant Streptokinase Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Recombinant Streptokinase Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Abbott Basic Information, Recombinant Streptokinase Manufacturing Base, Sales Area and Its Competitors
Table 79. Abbott Recombinant Streptokinase Product Portfolios and Specifications
Table 80. Abbott Recombinant Streptokinase Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Abbott Main Business
Table 82. Abbott Latest Developments
Table 83. Biocon Basic Information, Recombinant Streptokinase Manufacturing Base, Sales Area and Its Competitors
Table 84. Biocon Recombinant Streptokinase Product Portfolios and Specifications
Table 85. Biocon Recombinant Streptokinase Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Biocon Main Business
Table 87. Biocon Latest Developments
Table 88. Win Medicare Basic Information, Recombinant Streptokinase Manufacturing Base, Sales Area and Its Competitors
Table 89. Win Medicare Recombinant Streptokinase Product Portfolios and Specifications
Table 90. Win Medicare Recombinant Streptokinase Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Win Medicare Main Business
Table 92. Win Medicare Latest Developments
Table 93. Bharat Biotech Basic Information, Recombinant Streptokinase Manufacturing Base, Sales Area and Its Competitors
Table 94. Bharat Biotech Recombinant Streptokinase Product Portfolios and Specifications
Table 95. Bharat Biotech Recombinant Streptokinase Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Bharat Biotech Main Business
Table 97. Bharat Biotech Latest Developments
Table 98. Taj Pharma Basic Information, Recombinant Streptokinase Manufacturing Base, Sales Area and Its Competitors
Table 99. Taj Pharma Recombinant Streptokinase Product Portfolios and Specifications
Table 100. Taj Pharma Recombinant Streptokinase Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Taj Pharma Main Business
Table 102. Taj Pharma Latest Developments
Table 103. Stanex Drugs and Chemicals Pvt. Ltd. Basic Information, Recombinant Streptokinase Manufacturing Base, Sales Area and Its Competitors
Table 104. Stanex Drugs and Chemicals Pvt. Ltd. Recombinant Streptokinase Product Portfolios and Specifications
Table 105. Stanex Drugs and Chemicals Pvt. Ltd. Recombinant Streptokinase Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Stanex Drugs and Chemicals Pvt. Ltd. Main Business
Table 107. Stanex Drugs and Chemicals Pvt. Ltd. Latest Developments
Table 108. Qingdao Guoda Biopharmaceutical Co., Ltd. Basic Information, Recombinant Streptokinase Manufacturing Base, Sales Area and Its Competitors
Table 109. Qingdao Guoda Biopharmaceutical Co., Ltd. Recombinant Streptokinase Product Portfolios and Specifications
Table 110. Qingdao Guoda Biopharmaceutical Co., Ltd. Recombinant Streptokinase Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Qingdao Guoda Biopharmaceutical Co., Ltd. Main Business
Table 112. Qingdao Guoda Biopharmaceutical Co., Ltd. Latest Developments
Table 113. Shanghai Chemo Wanbang Biophama Basic Information, Recombinant Streptokinase Manufacturing Base, Sales Area and Its Competitors
Table 114. Shanghai Chemo Wanbang Biophama Recombinant Streptokinase Product Portfolios and Specifications
Table 115. Shanghai Chemo Wanbang Biophama Recombinant Streptokinase Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Shanghai Chemo Wanbang Biophama Main Business
Table 117. Shanghai Chemo Wanbang Biophama Latest Developments
List of Figures
Figure 1. Picture of Recombinant Streptokinase
Figure 2. Recombinant Streptokinase Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Recombinant Streptokinase Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Recombinant Streptokinase Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Recombinant Streptokinase Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Injection
Figure 10. Product Picture of Lyophilized
Figure 11. Global Recombinant Streptokinase Sales Market Share by Type in 2022
Figure 12. Global Recombinant Streptokinase Revenue Market Share by Type (2018-2023)
Figure 13. Recombinant Streptokinase Consumed in Hospital Pharmacies
Figure 14. Global Recombinant Streptokinase Market: Hospital Pharmacies (2018-2023) & (K Units)
Figure 15. Recombinant Streptokinase Consumed in Retail Pharmacies
Figure 16. Global Recombinant Streptokinase Market: Retail Pharmacies (2018-2023) & (K Units)
Figure 17. Recombinant Streptokinase Consumed in Online Pharmacies
Figure 18. Global Recombinant Streptokinase Market: Online Pharmacies (2018-2023) & (K Units)
Figure 19. Global Recombinant Streptokinase Sales Market Share by Application (2022)
Figure 20. Global Recombinant Streptokinase Revenue Market Share by Application in 2022
Figure 21. Recombinant Streptokinase Sales Market by Company in 2022 (K Units)
Figure 22. Global Recombinant Streptokinase Sales Market Share by Company in 2022
Figure 23. Recombinant Streptokinase Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Recombinant Streptokinase Revenue Market Share by Company in 2022
Figure 25. Global Recombinant Streptokinase Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Recombinant Streptokinase Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Recombinant Streptokinase Sales 2018-2023 (K Units)
Figure 28. Americas Recombinant Streptokinase Revenue 2018-2023 ($ Millions)
Figure 29. APAC Recombinant Streptokinase Sales 2018-2023 (K Units)
Figure 30. APAC Recombinant Streptokinase Revenue 2018-2023 ($ Millions)
Figure 31. Europe Recombinant Streptokinase Sales 2018-2023 (K Units)
Figure 32. Europe Recombinant Streptokinase Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Recombinant Streptokinase Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Recombinant Streptokinase Revenue 2018-2023 ($ Millions)
Figure 35. Americas Recombinant Streptokinase Sales Market Share by Country in 2022
Figure 36. Americas Recombinant Streptokinase Revenue Market Share by Country in 2022
Figure 37. Americas Recombinant Streptokinase Sales Market Share by Type (2018-2023)
Figure 38. Americas Recombinant Streptokinase Sales Market Share by Application (2018-2023)
Figure 39. United States Recombinant Streptokinase Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Recombinant Streptokinase Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Recombinant Streptokinase Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Recombinant Streptokinase Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Recombinant Streptokinase Sales Market Share by Region in 2022
Figure 44. APAC Recombinant Streptokinase Revenue Market Share by Regions in 2022
Figure 45. APAC Recombinant Streptokinase Sales Market Share by Type (2018-2023)
Figure 46. APAC Recombinant Streptokinase Sales Market Share by Application (2018-2023)
Figure 47. China Recombinant Streptokinase Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Recombinant Streptokinase Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Recombinant Streptokinase Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Recombinant Streptokinase Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Recombinant Streptokinase Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Recombinant Streptokinase Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Recombinant Streptokinase Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Recombinant Streptokinase Sales Market Share by Country in 2022
Figure 55. Europe Recombinant Streptokinase Revenue Market Share by Country in 2022
Figure 56. Europe Recombinant Streptokinase Sales Market Share by Type (2018-2023)
Figure 57. Europe Recombinant Streptokinase Sales Market Share by Application (2018-2023)
Figure 58. Germany Recombinant Streptokinase Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Recombinant Streptokinase Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Recombinant Streptokinase Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Recombinant Streptokinase Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Recombinant Streptokinase Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Recombinant Streptokinase Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Recombinant Streptokinase Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Recombinant Streptokinase Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Recombinant Streptokinase Sales Market Share by Application (2018-2023)
Figure 67. Egypt Recombinant Streptokinase Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Recombinant Streptokinase Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Recombinant Streptokinase Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Recombinant Streptokinase Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Recombinant Streptokinase Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Recombinant Streptokinase in 2022
Figure 73. Manufacturing Process Analysis of Recombinant Streptokinase
Figure 74. Industry Chain Structure of Recombinant Streptokinase
Figure 75. Channels of Distribution
Figure 76. Global Recombinant Streptokinase Sales Market Forecast by Region (2024-2029)
Figure 77. Global Recombinant Streptokinase Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Recombinant Streptokinase Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Recombinant Streptokinase Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Recombinant Streptokinase Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Recombinant Streptokinase Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の組換えストレプトキナーゼ市場予測 2023年-2029年] (コード：LP23DC01063)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の組換えストレプトキナーゼ市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の吸入用組換え新型コロナウイルスワクチン市場予測 2023年-2029年
  • 世界の組換えヒト血清アルブミン市場予測 2023年-2029年
  • 世界の抗ミュラー管ホルモン（AMH）市場予測 2023年-2029年
  • 世界のTRPV3モノクローナル抗体市場予測 2023年-2029年
  • 世界のホスホセリンモノクローナル抗体市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆